These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 31835306

  • 1. Transthyretin Anti-Amyloidogenic and Fibril Disrupting Activities of Bacopa monnieri (L.) Wettst (Brahmi) Extract.
    Eze FN, Ingkaninan K, Prapunpoj P.
    Biomolecules; 2019 Dec 09; 9(12):. PubMed ID: 31835306
    [Abstract] [Full Text] [Related]

  • 2. Trapping the monomer of a non-amyloidogenic variant of transthyretin: exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases.
    Palhano FL, Leme LP, Busnardo RG, Foguel D.
    J Biol Chem; 2009 Jan 16; 284(3):1443-53. PubMed ID: 18984591
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA, Lai Z, Kelly JW.
    Biochemistry; 1998 Dec 22; 37(51):17851-64. PubMed ID: 9922152
    [Abstract] [Full Text] [Related]

  • 4. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
    Hurshman Babbes AR, Powers ET, Kelly JW.
    Biochemistry; 2008 Jul 01; 47(26):6969-84. PubMed ID: 18537267
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis.
    Eze FN, Leelawatwattana L, Prapunpoj P.
    Biomolecules; 2019 Mar 29; 9(4):. PubMed ID: 30934952
    [Abstract] [Full Text] [Related]

  • 7. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
    Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson MD, Ando Y.
    J Biol Chem; 2019 Jul 19; 294(29):11259-11275. PubMed ID: 31167790
    [Abstract] [Full Text] [Related]

  • 8. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.
    Miller SR, Sekijima Y, Kelly JW.
    Lab Invest; 2004 May 19; 84(5):545-52. PubMed ID: 14968122
    [Abstract] [Full Text] [Related]

  • 9. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.
    Lashuel HA, Wurth C, Woo L, Kelly JW.
    Biochemistry; 1999 Oct 12; 38(41):13560-73. PubMed ID: 10521263
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution.
    Quintas A, Saraiva MJ, Brito RM.
    FEBS Lett; 1997 Dec 01; 418(3):297-300. PubMed ID: 9428731
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin.
    Shnyrov VL, Villar E, Zhadan GG, Sanchez-Ruiz JM, Quintas A, Saraiva MJ, Brito RM.
    Biophys Chem; 2000 Dec 15; 88(1-3):61-7. PubMed ID: 11152276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.
    Foss TR, Kelker MS, Wiseman RL, Wilson IA, Kelly JW.
    J Mol Biol; 2005 Apr 08; 347(4):841-54. PubMed ID: 15769474
    [Abstract] [Full Text] [Related]

  • 18. In vivo stabilization of mutant human transthyretin in transgenic mice.
    Tagoe CE, Reixach N, Friske L, Mustra D, French D, Gallo G, Buxbaum JN.
    Amyloid; 2007 Sep 08; 14(3):227-36. PubMed ID: 17701470
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.